Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christina Aquilante

Concepts (356)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
175
6.030
 Why?
Pharmacogenomic Testing
16
2026
63
4.400
 Why?
Thiazolidinediones
8
2016
143
2.530
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
45
2.220
 Why?
Heart Transplantation
9
2024
680
2.080
 Why?
Polymorphism, Genetic
17
2019
615
2.050
 Why?
Organ Transplantation
3
2024
253
1.640
 Why?
Cytochrome P-450 CYP3A
8
2024
93
1.540
 Why?
Precision Medicine
11
2025
461
1.470
 Why?
Genotype
20
2025
1857
1.430
 Why?
Polymorphism, Single Nucleotide
11
2024
2181
1.380
 Why?
Tacrolimus
3
2024
196
1.380
 Why?
Cytochrome P-450 CYP2C19
6
2024
27
1.290
 Why?
Health Personnel
4
2021
757
1.200
 Why?
Transplant Recipients
6
2024
182
1.170
 Why?
Hypoglycemic Agents
11
2020
1399
1.150
 Why?
Decision Support Systems, Clinical
2
2024
273
1.080
 Why?
Graft Rejection
3
2024
521
1.050
 Why?
Blood Pressure
8
2020
1782
1.040
 Why?
Metabolic Syndrome
4
2016
361
0.980
 Why?
Cytochrome P-450 CYP2D6
4
2022
32
0.960
 Why?
Immunosuppressive Agents
6
2024
838
0.860
 Why?
Pharmacists
3
2022
258
0.840
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
444
0.760
 Why?
Cost-Benefit Analysis
3
2024
644
0.720
 Why?
Gemfibrozil
2
2013
9
0.710
 Why?
Sulfonylurea Compounds
3
2018
51
0.680
 Why?
Adiponectin
2
2016
242
0.680
 Why?
Leukopenia
1
2021
33
0.680
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
21
0.680
 Why?
Hypolipidemic Agents
2
2013
89
0.670
 Why?
Dihydrouracil Dehydrogenase (NADP)
3
2026
5
0.670
 Why?
Warfarin
4
2024
179
0.650
 Why?
Mycophenolic Acid
1
2021
119
0.640
 Why?
Desogestrel
5
2021
46
0.630
 Why?
Organic Anion Transporters
2
2011
13
0.630
 Why?
Biological Specimen Banks
2
2024
118
0.620
 Why?
Platelet Aggregation Inhibitors
1
2024
499
0.620
 Why?
Hypertension
3
2020
1276
0.610
 Why?
Humans
83
2026
145783
0.590
 Why?
Prescription Drugs
2
2020
111
0.570
 Why?
Cytochrome P-450 CYP2C8
7
2014
14
0.560
 Why?
Cardiologists
1
2018
45
0.560
 Why?
Adult
43
2024
40881
0.540
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.530
 Why?
Middle Aged
41
2024
36309
0.530
 Why?
HIV Protease Inhibitors
4
2016
69
0.520
 Why?
Physicians
3
2021
956
0.520
 Why?
Ritonavir
4
2012
75
0.500
 Why?
Academic Medical Centers
1
2020
554
0.490
 Why?
Antimetabolites, Antineoplastic
3
2026
106
0.480
 Why?
Male
48
2024
73011
0.470
 Why?
Female
52
2024
79045
0.470
 Why?
Polypharmacy
1
2017
94
0.470
 Why?
Heart Failure
4
2017
2326
0.470
 Why?
Fluorouracil
3
2026
231
0.460
 Why?
Lectins
1
2016
44
0.460
 Why?
Nonprescription Drugs
1
2016
69
0.460
 Why?
Antiviral Agents
1
2021
769
0.440
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.430
 Why?
Attitude of Health Personnel
2
2020
1197
0.430
 Why?
Cytochrome P-450 Enzyme System
2
2006
162
0.420
 Why?
Contraceptive Agents, Female
3
2020
80
0.420
 Why?
Medicare
1
2020
904
0.410
 Why?
Death, Sudden, Cardiac
3
2021
237
0.400
 Why?
Pediatrics
2
2021
1125
0.390
 Why?
Blood Pressure Determination
1
2014
145
0.390
 Why?
Chemokine CXCL5
3
2012
19
0.380
 Why?
Heptanoic Acids
1
2013
67
0.380
 Why?
Arrhythmias, Cardiac
3
2021
356
0.370
 Why?
Pharmaceutical Preparations
3
2009
171
0.360
 Why?
Pyrazines
1
2013
94
0.360
 Why?
Resistin
2
2010
12
0.350
 Why?
Pravastatin
1
2011
45
0.350
 Why?
Pyrroles
1
2013
220
0.340
 Why?
Anticoagulants
3
2024
748
0.340
 Why?
Triazoles
1
2013
191
0.340
 Why?
Dobutamine
3
2008
24
0.340
 Why?
Diabetes Mellitus, Type 2
5
2020
2602
0.330
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1420
0.330
 Why?
Retrospective Studies
15
2024
17330
0.330
 Why?
Cross-Sectional Studies
8
2020
5925
0.320
 Why?
Managed Care Programs
2
2022
140
0.320
 Why?
Antidepressive Agents
2
2022
242
0.300
 Why?
Mixed Function Oxygenases
2
2008
43
0.300
 Why?
DNA
1
2016
1437
0.300
 Why?
Aged
19
2024
26217
0.290
 Why?
Drug Interactions
5
2017
405
0.290
 Why?
Chromatography, Liquid
1
2010
450
0.280
 Why?
Polymerase Chain Reaction
3
2006
1043
0.280
 Why?
Health
1
2008
82
0.270
 Why?
Cytokines
1
2016
2069
0.270
 Why?
Drug Prescriptions
4
2021
288
0.270
 Why?
International Normalized Ratio
2
2024
55
0.270
 Why?
Chemokine CCL2
1
2008
112
0.260
 Why?
Sulfonamides
1
2011
583
0.260
 Why?
Receptors, Adrenergic, beta
1
2008
58
0.260
 Why?
Mass Spectrometry
1
2010
732
0.260
 Why?
Drug Implants
4
2021
83
0.260
 Why?
Time Factors
8
2020
7134
0.260
 Why?
Young Adult
13
2021
14254
0.250
 Why?
Electronic Health Records
4
2026
1202
0.250
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.250
 Why?
Heart Rate
3
2008
856
0.250
 Why?
Haplotypes
5
2013
500
0.250
 Why?
Sequence Analysis, DNA
4
2012
778
0.250
 Why?
Blood Glucose
3
2016
2344
0.240
 Why?
United States
12
2025
16126
0.240
 Why?
Metoprolol
1
2006
26
0.240
 Why?
Vitamin K Epoxide Reductases
3
2020
12
0.240
 Why?
Clinical Laboratory Techniques
1
2006
96
0.230
 Why?
Autonomic Nervous System
1
2006
83
0.230
 Why?
Prospective Studies
7
2024
8078
0.230
 Why?
Models, Biological
1
2013
1764
0.220
 Why?
Blood Coagulation Factors
1
2006
71
0.220
 Why?
Clinical Protocols
2
2017
280
0.220
 Why?
Capecitabine
1
2025
56
0.220
 Why?
Administration, Oral
4
2016
867
0.220
 Why?
Genetic Variation
3
2019
977
0.210
 Why?
Echocardiography
1
2008
648
0.210
 Why?
Adrenergic beta-Antagonists
1
2006
252
0.210
 Why?
Echocardiography, Stress
1
2004
29
0.210
 Why?
Polymorphism, Restriction Fragment Length
1
2004
60
0.210
 Why?
Cross-Over Studies
3
2013
610
0.210
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
81
0.210
 Why?
Carrier Proteins
1
2008
729
0.200
 Why?
United States Food and Drug Administration
1
2024
208
0.200
 Why?
Follow-Up Studies
5
2024
5428
0.200
 Why?
Biotransformation
2
2013
62
0.200
 Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.190
 Why?
Metformin
1
2007
329
0.190
 Why?
Cohort Studies
7
2021
6033
0.190
 Why?
Alleles
6
2012
896
0.190
 Why?
Waist Circumference
2
2016
143
0.190
 Why?
Gene Frequency
4
2013
489
0.180
 Why?
Dose-Response Relationship, Drug
4
2024
2028
0.170
 Why?
Antimalarials
2
2013
35
0.170
 Why?
Clinical Trials as Topic
1
2006
1062
0.170
 Why?
Drug Dosage Calculations
1
2020
27
0.160
 Why?
Calcineurin Inhibitors
1
2021
69
0.160
 Why?
Aged, 80 and over
5
2024
8347
0.160
 Why?
Pharmacogenomic Variants
2
2021
35
0.160
 Why?
Egypt
1
2020
13
0.160
 Why?
Atazanavir Sulfate
3
2016
42
0.160
 Why?
Antibiotics, Antineoplastic
1
2021
140
0.160
 Why?
Cytomegalovirus
1
2021
168
0.160
 Why?
Area Under Curve
2
2013
332
0.150
 Why?
No-Show Patients
1
2019
3
0.150
 Why?
Menstruation Disturbances
1
2019
13
0.150
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
69
0.150
 Why?
Smoking
1
2006
1477
0.150
 Why?
Diabetes Mellitus
2
2024
1101
0.150
 Why?
Brain Chemistry
1
2000
120
0.150
 Why?
Cytochrome P450 Family 3
1
2019
3
0.150
 Why?
Cardiovascular Diseases
3
2024
2191
0.150
 Why?
Colorado
3
2024
4556
0.150
 Why?
Hemodynamics
1
2004
1118
0.140
 Why?
Body Weight
2
2016
972
0.140
 Why?
Oligopeptides
2
2012
267
0.140
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
346
0.140
 Why?
Morphine
1
2000
169
0.140
 Why?
Patients
1
2020
183
0.140
 Why?
Child Health Services
1
2020
186
0.140
 Why?
Sitagliptin Phosphate
2
2021
31
0.140
 Why?
Progesterone
1
2019
215
0.140
 Why?
Double-Blind Method
2
2016
2064
0.140
 Why?
Lipids
2
2016
707
0.140
 Why?
Ventricular Dysfunction
1
2018
16
0.130
 Why?
Psychiatry
1
2020
195
0.130
 Why?
Body Mass Index
3
2019
2447
0.130
 Why?
Treatment Outcome
7
2024
11794
0.130
 Why?
Organophosphonates
2
2008
95
0.130
 Why?
Apyrase
1
2017
27
0.130
 Why?
Healthy Volunteers
2
2019
219
0.130
 Why?
Bariatric Surgery
1
2021
253
0.130
 Why?
DNA Primers
3
2006
505
0.120
 Why?
Pyrophosphatases
1
2016
26
0.120
 Why?
Chronic Disease
2
2017
1812
0.120
 Why?
Pyridines
2
2012
609
0.120
 Why?
Ribavirin
1
2016
81
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
267
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.110
 Why?
Students, Pharmacy
1
2016
96
0.110
 Why?
Patient Care
1
2016
120
0.110
 Why?
Cardiology
1
2018
362
0.110
 Why?
Depression
2
2022
1559
0.110
 Why?
Circadian Rhythm
1
2020
513
0.110
 Why?
Metabolic Clearance Rate
2
2013
115
0.110
 Why?
Anti-HIV Agents
2
2016
912
0.110
 Why?
Therapeutics
1
2015
14
0.110
 Why?
Adenine
2
2008
339
0.110
 Why?
Delivery of Health Care
1
2022
948
0.110
 Why?
Voriconazole
1
2015
21
0.110
 Why?
Education, Pharmacy
1
2016
120
0.110
 Why?
beta-Cyclodextrins
1
2015
32
0.110
 Why?
Surveys and Questionnaires
3
2026
6085
0.110
 Why?
Diltiazem
1
2014
17
0.100
 Why?
HIV Infections
4
2016
3195
0.100
 Why?
Renal Replacement Therapy
1
2015
100
0.100
 Why?
Surgical Procedures, Operative
1
2017
271
0.100
 Why?
Patient Education as Topic
1
2019
777
0.100
 Why?
Phenotype
3
2024
3170
0.100
 Why?
Antifungal Agents
1
2015
152
0.100
 Why?
Chromosomes, Human, Pair 10
1
2013
20
0.100
 Why?
Antigens, CD
1
2017
558
0.100
 Why?
Cardiomyopathies
1
2017
335
0.100
 Why?
Reoperation
1
2016
637
0.100
 Why?
Kidney Transplantation
1
2019
712
0.100
 Why?
Neoplasms
2
2026
2913
0.090
 Why?
Adolescent
6
2021
22577
0.090
 Why?
Half-Life
1
2013
155
0.090
 Why?
Medication Adherence
1
2017
540
0.090
 Why?
Venous Thromboembolism
1
2017
328
0.090
 Why?
Liver Transplantation
1
2019
827
0.090
 Why?
Sirolimus
1
2014
282
0.090
 Why?
Tissue Distribution
2
2014
335
0.090
 Why?
Darunavir
1
2011
20
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1372
0.080
 Why?
Self Care
1
2014
392
0.080
 Why?
Genetic Association Studies
1
2013
371
0.080
 Why?
Acquired Immunodeficiency Syndrome
1
2012
237
0.080
 Why?
Lung Transplantation
1
2014
332
0.080
 Why?
Reverse Transcriptase Inhibitors
2
2008
87
0.080
 Why?
Insulin Resistance
2
2010
1244
0.080
 Why?
Genetic Testing
2
2025
483
0.080
 Why?
Prevalence
1
2017
2875
0.080
 Why?
Cholesterol
1
2011
408
0.080
 Why?
Patient Discharge
1
2016
995
0.070
 Why?
Triglycerides
1
2011
520
0.070
 Why?
ATP-Binding Cassette Transporters
1
2010
117
0.070
 Why?
Leukocytes
2
2012
296
0.070
 Why?
Lipoproteins
1
2010
166
0.070
 Why?
Kidney Failure, Chronic
1
2015
599
0.070
 Why?
Longitudinal Studies
1
2016
2968
0.070
 Why?
Risk Assessment
3
2020
3752
0.070
 Why?
Lung Diseases
1
2014
782
0.060
 Why?
Incidence
2
2020
2934
0.060
 Why?
Databases, Factual
3
2021
1491
0.060
 Why?
Indinavir
1
2006
7
0.060
 Why?
Weight Gain
2
2021
561
0.060
 Why?
Linear Models
2
2019
849
0.060
 Why?
Pyrimidinones
1
2007
125
0.060
 Why?
Genetic Techniques
1
2006
66
0.060
 Why?
Drug Delivery Systems
1
2010
381
0.060
 Why?
Zidovudine
1
2006
77
0.060
 Why?
Lamivudine
1
2006
65
0.060
 Why?
Factor X
1
2006
26
0.060
 Why?
Prothrombin
1
2006
25
0.060
 Why?
Factor VII
1
2006
24
0.060
 Why?
Drug Utilization
1
2007
168
0.060
 Why?
Chemokines, CXC
1
2006
68
0.060
 Why?
Reproducibility of Results
1
2014
3418
0.060
 Why?
Base Sequence
2
2006
2171
0.060
 Why?
C-Reactive Protein
1
2008
423
0.060
 Why?
Oxidation-Reduction
1
2009
1069
0.060
 Why?
Regression Analysis
1
2008
1001
0.060
 Why?
Biomarkers
3
2014
4302
0.060
 Why?
Prognosis
2
2014
4330
0.060
 Why?
Health Care Surveys
1
2007
536
0.060
 Why?
Delayed-Action Preparations
1
2006
189
0.060
 Why?
Pharmacovigilance
1
2024
24
0.050
 Why?
Gene Expression Regulation
1
2014
2601
0.050
 Why?
Mathematical Computing
1
2004
11
0.050
 Why?
Gene Expression
1
2009
1478
0.050
 Why?
Drug Labeling
1
2004
37
0.050
 Why?
Risk Factors
3
2020
10919
0.050
 Why?
Laboratories
1
2004
110
0.050
 Why?
Infusions, Intravenous
1
2004
428
0.050
 Why?
Reference Values
1
2004
798
0.050
 Why?
Algorithms
3
2024
1851
0.050
 Why?
Kidney
2
2008
1497
0.050
 Why?
Socioeconomic Factors
1
2007
1327
0.050
 Why?
Blood Coagulation
1
2024
274
0.040
 Why?
Linagliptin
1
2021
5
0.040
 Why?
Adamantane
1
2021
18
0.040
 Why?
Administrative Claims, Healthcare
1
2021
28
0.040
 Why?
Dipeptides
1
2021
56
0.040
 Why?
Electronic Prescribing
1
2021
4
0.040
 Why?
Uterine Hemorrhage
1
2021
41
0.040
 Why?
Electrocardiography
1
2004
668
0.040
 Why?
Drug Monitoring
1
2024
401
0.040
 Why?
Protective Factors
1
2020
99
0.040
 Why?
Drug Tolerance
1
2000
99
0.040
 Why?
Costs and Cost Analysis
1
2020
221
0.040
 Why?
Treatment Failure
1
2020
360
0.040
 Why?
Homozygote
2
2012
199
0.040
 Why?
Kaplan-Meier Estimate
1
2021
971
0.040
 Why?
Animals
3
2008
38102
0.040
 Why?
Sex Factors
1
2024
2110
0.030
 Why?
Genomics
1
2024
830
0.030
 Why?
Attitude
1
2020
259
0.030
 Why?
Glipizide
1
2018
6
0.030
 Why?
Glyburide
1
2018
31
0.030
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.030
 Why?
Antineoplastic Agents
1
2009
2219
0.030
 Why?
Proportional Hazards Models
1
2021
1330
0.030
 Why?
Dexamethasone
1
2000
365
0.030
 Why?
Social Class
1
2019
264
0.030
 Why?
Liver
1
2006
1899
0.030
 Why?
Feasibility Studies
1
2021
1115
0.030
 Why?
Self Report
1
2021
876
0.030
 Why?
Membrane Transport Proteins
2
2008
154
0.030
 Why?
Self-Management
1
2019
204
0.030
 Why?
Pharmaceutical Services
1
2016
76
0.030
 Why?
Peru
1
2016
60
0.030
 Why?
Anesthetics
1
2017
100
0.030
 Why?
Indians, North American
1
2021
598
0.030
 Why?
Diabetic Angiopathies
1
2018
267
0.030
 Why?
Medicaid
1
2020
467
0.030
 Why?
Tenofovir
2
2008
301
0.030
 Why?
Cause of Death
1
2018
472
0.030
 Why?
South Africa
1
2016
266
0.030
 Why?
Alternative Splicing
1
2017
248
0.030
 Why?
Perioperative Care
1
2017
231
0.030
 Why?
Hepatitis C, Chronic
1
2016
153
0.030
 Why?
HEK293 Cells
1
2017
741
0.030
 Why?
Preoperative Care
1
2017
380
0.030
 Why?
Receptors, Steroid
1
2014
42
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2525
0.030
 Why?
Everolimus
1
2014
112
0.020
 Why?
Demography
1
2014
282
0.020
 Why?
Hypoglycemia
1
2018
480
0.020
 Why?
Vasodilator Agents
1
2014
330
0.020
 Why?
Age Factors
1
2019
3346
0.020
 Why?
Heterozygote
1
2012
314
0.020
 Why?
Rats
1
2000
5585
0.020
 Why?
Genetic Loci
1
2012
267
0.020
 Why?
Mental Disorders
1
2020
1171
0.020
 Why?
Multivariate Analysis
1
2012
1547
0.020
 Why?
Insulin
1
2019
2516
0.020
 Why?
Body Composition
1
2012
693
0.020
 Why?
Critical Illness
1
2015
900
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2399
0.020
 Why?
Plasma
1
2009
223
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
15
0.010
 Why?
Ribosomal Proteins
1
2006
93
0.010
 Why?
Antiretroviral Therapy, Highly Active
1
2007
279
0.010
 Why?
Pharmacology
1
2005
10
0.010
 Why?
Molecular Sequence Data
1
2009
2883
0.010
 Why?
Likelihood Functions
1
2005
138
0.010
 Why?
Cardiotonic Agents
1
2005
94
0.010
 Why?
RNA, Messenger
1
2012
2805
0.010
 Why?
Mitochondrial Proteins
1
2006
263
0.010
 Why?
Chromosome Mapping
1
2005
507
0.010
 Why?
Genome
1
2006
305
0.010
 Why?
Drug Therapy, Combination
1
2006
1043
0.010
 Why?
Hemorrhage
1
2008
822
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
414
0.010
 Why?
Predictive Value of Tests
1
2008
2123
0.010
 Why?
Models, Genetic
1
2005
527
0.010
 Why?
Child
1
2020
22740
0.010
 Why?
Pilot Projects
1
2006
1898
0.010
 Why?
Computer Simulation
1
2005
1003
0.010
 Why?
Case-Control Studies
1
2007
3634
0.010
 Why?
Inflammation
1
2006
2884
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (356) concept(s)
_
Co-Authors Expand Description
See all (55) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)